Arcticzymes Technologies ASA (AZT)

Currency in NOK
28.40
-0.10(-0.35%)
Closed·
AZT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
AZT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
28.4029.10
52 wk Range
12.3430.90
Key Statistics
Prev. Close
28.5
Open
29.1
Day's Range
28.4-29.1
52 wk Range
12.34-30.9
Volume
19.11K
Average Volume (3m)
39.32K
1-Year Change
44.96%
Book Value / Share
6.39
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AZT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
29.00
Upside
+2.11%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Arcticzymes Technologies ASA Company Profile

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA. It also provides DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. The company serves the molecular tools, such as research and diagnostics, and biomanufacturing markets. It operates in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.

Arcticzymes Technologies ASA Earnings Call Summary for Q2/2025

  • Q2 2025 revenues reached 29 million NOK, up 1% YoY; EBITDA improved to 3.9 million NOK from 2.76 million NOK last year
  • Biomanufacturing sales grew 50% YoY to 18.1 million NOK, offsetting decline in molecular tools segment
  • Stock surged 32.29% post-earnings to 19.2 NOK; company maintains strong cash position of 247 million SEK
  • Management expects continued growth in biomanufacturing, recovery in molecular tools, and explores CDMO partnerships
  • No new enzyme launches planned for 2025; moderate growth reported in emerging markets like India and China
Last Updated: 14/08/2025, 09:00
Read Full Transcript

Compare AZT to Peers and Sector

Metrics to compare
AZT
Peers
Sector
Relationship
P/E Ratio
519.3x−2.8x−0.6x
PEG Ratio
−6.69−0.030.00
Price/Book
4.5x1.3x2.6x
Price / LTM Sales
14.0x7.9x3.3x
Upside (Analyst Target)
1.8%62.9%39.1%
Fair Value Upside
Unlock23.5%5.4%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 29.00
(+2.11% Upside)

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
0.06 / 0.025
Revenue / Forecast
27.90M / 25.95M
EPS Revisions
Last 90 days

AZT Income Statement

FAQ

What Stock Exchange Does Arcticzymes Tech Trade On?

Arcticzymes Tech is listed and trades on the Oslo Stock Exchange stock exchange.

What Is the Stock Symbol for Arcticzymes Tech?

The stock symbol for Arcticzymes Tech is "AZT."

What Is the Arcticzymes Tech Market Cap?

As of today, Arcticzymes Tech market cap is 1.45B.

What Is Arcticzymes Tech's Earnings Per Share (TTM)?

The Arcticzymes Tech EPS (TTM) is 0.05.

When Is the Next Arcticzymes Tech Earnings Date?

Arcticzymes Tech will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is AZT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Arcticzymes Tech Stock Split?

Arcticzymes Tech has split 1 times.

How Many Employees Does Arcticzymes Tech Have?

Arcticzymes Tech has 53 employees.

What is the current trading status of Arcticzymes Tech (AZT)?

As of 29 Aug 2025, Arcticzymes Tech (AZT) is trading at a price of 28.40, with a previous close of 28.50. The stock has fluctuated within a day range of 28.40 to 29.10, while its 52-week range spans from 12.34 to 30.90.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.